Ligand Pharmaceuticals Incorporated Long-term Investment Intensity
Ligand Pharmaceuticals Incorporated long-term investment intensity. Ligand Pharmaceuticals Incorporated (LGND) has a Long-term Investment Intensity of 20.4% as of March 2026. Long-term investments of $312.82 Million represent 20.4% of total assets of $1.53 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See working capital position of Ligand Pharmaceuticals Incorporated to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Ligand Pharmaceuticals Incorporated (2012–2025)
Long-term investment intensity of Ligand Pharmaceuticals Incorporated from 2012 to 2025. This chart shows how Ligand Pharmaceuticals Incorporated's Long-term Investment Intensity has evolved across 9 annual periods from 2012 to 2025. As of March 2026, the intensity stands at 20.4%, reflecting long-term investments of $312.82 Million against total assets of $1.53 Billion USD. See how many days can Ligand Pharmaceuticals Incorporated fund operations to measure how many days the company can operate on defensive assets alone.
Ligand Pharmaceuticals Incorporated Long-term Investment Intensity by Year (2012–2025)
Ligand Pharmaceuticals Incorporated long-term investment intensity by year from 2012 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Ligand Pharmaceuticals Incorporated from 2012 to 2025, covering 9 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see LGND asset base.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 23.4% | $364.83 Million | $1.56 Billion | ▲ +2.6 pp |
| 2024 | 20.8% | $195.93 Million | $941.77 Million | ▲ +14.7 pp |
| 2023 | 6.1% | $48.32 Million | $787.22 Million | ▲ +5.7 pp |
| 2022 | 0.4% | $3.00 Million | $762.67 Million | ▼ -0.6 pp |
| 2017 | 1.0% | $6.44 Million | $671.02 Million | ▼ -0.4 pp |
| 2016 | 1.4% | $8.35 Million | $601.59 Million | ▼ -4.2 pp |
| 2015 | 5.6% | $29.73 Million | $533.93 Million | ▲ +2.7 pp |
| 2014 | 2.9% | $7.42 Million | $258.03 Million | ▼ -5.0 pp |
| 2012 | 7.9% | $8.21 Million | $104.26 Million | — |